Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
European Journal of Haematology. Supplementum|August 7, 2001
Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patientsE Aurlien, H Holte, S Kvaløy, et al.European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's diseaseV Bonfante, S Viviani, L Devizzi, et al.European Journal of Haematology. Supplementum|July 11, 1998
A review of the use of teicoplanin in haematological malignancyJ M DaviesEuropean Journal of Haematology. Supplementum|July 11, 1998
Patient education and communication in non-inpatient intravenous therapy--a reviewJ M Davies, A C Newland, R G FinchEuropean Journal of Haematology. Supplementum|January 1, 1996
Drugs in the aetiology of agranulocytosis and aplastic anaemiaD W Kaufman, J P Kelly, J M Jurgelon, et al.European Journal of Haematology. Supplementum|January 1, 1996
Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994B E Wiholm, S EmanuelssonEuropean Journal of Haematology. Supplementum|January 1, 1996
Could aplastic anaemia be considered a pre-pre-leukaemic disorder?G SociéEuropean Journal of Haematology. Supplementum|January 1, 1996
Reactive metabolites and agranulocytosisJ P UetrechtEuropean Journal of Haematology. Supplementum|January 1, 1993
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patientsA W Chow, P J Jewesson, A Kureishi, et al.European Journal of Haematology. Supplementum|January 1, 1993
Teicoplanin in gram-positive infection: microbiological aspectsR C SpencerPageof 14